Prevacid, Lansoprazole
Prevacid, Lansoprazole Newswire

Prevacid, Lansoprazole Newswire

Comprehensive Real-Time News Feed for Prevacid, Lansoprazole (generic).

Results 1 - 20 of 50 in Prevacid, Lansoprazole (generic)

  1. FDA Approves Takeda's Dexilant SoluTabRead the original story

    Tuesday Jan 26 | BioSpace

    Food and Drug Administration approved Dexilant SoluTab delayed-release orally disintegrating tablets, a new formulation of dexlansoprazole that can be taken by allowing the tablet to melt in the patient's mouth. Dexilant SoluTab is a proton pump inhibitor indicated for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease and the maintenance of healed erosive esophagitis and relief of heartburn in adults 18 years and older.

    Comment?

  2. FDA Approves Takeda's Dexilant SoluTabRead the original story

    Wednesday Jan 27 | Freshnews

    Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration approved Dexilant SoluTab delayed-release orally disintegrating tablets, a new formulation of dexlansoprazole that can be taken by allowing the tablet to melt in the patient's mouth. Dexilant SoluTab is a proton pump inhibitor indicated for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease and the maintenance of healed erosive esophagitis and relief of heartburn in adults 18 years and older.

    Comment?

  3. Colorcon sweetens its offering with Paulaur's pharma sugar sphere bizRead the original story w/Photo

    Tuesday Jan 19 | In-PharmaTechnologist.com

    Excipient and coating maker Colorcon has sugar sphere manufacturing sites in the US and France which have both seen expansions over the past few years, but the addition of Paulaur's pharmaceutical sphere business will bolster the firm further, spokesperson Deborah Taylor said. "This acquisition complements Colorcon's existing spheres and film coatings business," she told in-Pharmatechnologist.com.

    Comment?

  4. Different effects of proton pump inhibitors and famotidine on the...Read the original story

    Dec 15, 2015 | CiteULike

    Inhibitory potential of proton pump inhibitors and famotidine, an H receptor antagonist, on the metabolic activation of clopidogrel was evaluated using recombinant CYP2B6, CYP2C19 and CYP3A4. Formation of the active metabolite from an intermediate metabolite, 2-oxo-clopidogrel, was investigated by liquid chromatography-tandem mass spectrometry and three peaks corresponding to the pharmacologically active metabolite and its stereoisomers were detected.

    Comment?

  5. Comparative risk of ischemic stroke among users of clopidogrel...Read the original story

    Dec 15, 2015 | CiteULike

    There is controversy and little information about whether individual proton pump inhibitors differentially alter the effectiveness of clopidogrel in reducing ischemic stroke risk. We, therefore, aimed to elucidate the risk of ischemic stroke among concomitant users of clopidogrel and individual PPIs.

    Comment?

  6. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.Read the original story

    Dec 15, 2015 | CiteULike

    Proton-pump inhibitors are recommended for patients who require antiplatelet therapy and have a history of upper gastrointestinal bleeding. Proton-pump inhibitors should also be considered for patients receiving antiplatelet therapy who have other risk factors for gastrointestinal bleeding, including use of aspirin.

    Comment?

  7. The proton pump inhibitor, omeprazole, but not lansoprazole or...Read the original story

    Dec 15, 2015 | CiteULike

    The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?

  8. Lansoprazole 3 mg/mL Oral SuspensionRead the original story

    Dec 14, 2015 | US Pharmacist

    Calculate the quantity of each ingredient for the amount to be prepared. Accurately weigh or measure each ingredient or obtain the required number of lansoprazole 30 mg delayed-release capsules.

    Comment?

  9. Analysts' Updated EPS Estimates for December, 9th (CBT, GRA, HXL,...Read the original story w/Photo

    Dec 9, 2015 | AmericanBankingNews.com

    According to Zacks, "Tag-It Pacific, Inc. is a single-source provider of complete brand identity programs to manufacturers of fashion apparel & accessories as well as specialty retailers & mass merchandisers. Such programs communicate a certain lifestyle,image or identity & enable the Co's customers to promote & differentiate their product line or brand.

    Comment?

  10. Medicare open enrollment offers opportunity for savingsRead the original story

    Oct 15, 2015 | UB Reporter

    Medicare's open enrollment period, which runs Oct. 15 through Dec. 7, gives beneficiaries nearly two months to re-evaluate their prescription drug plans and make a change that could cut their costs by nearly one-third. But only 10 percent actually make a switch, despite the fact that research shows only 12 percent of people are in the least expensive plan.

    Comment?

  11. "It's the last thing people talk about" - York woman speaks out about common but deadly diseaseRead the original story w/Photo

    Oct 13, 2015 | York Press

    We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience.

    Comment?

  12. Medicare open enrollment offers opportunity for savings, but few beneficiaries change plansRead the original story

    Oct 9, 2015 | University at Buffalo

    BUFFALO, N.Y. Medicare's open enrollment period, which runs Oct. 15 through Dec. 7, gives beneficiaries nearly two months to re-evaluate their prescription drug plans and make a change that could cut their costs by nearly one-third. But only 10 percent actually make a switch, despite the fact that research shows only 12 percent of people are in the least expensive plan.

    Comment?

  13. Perils and pitfalls of long-term effects of proton pump inhibitors.Read the original story

    Sep 26, 2015 | CiteULike

    This review summarizes the literature regarding long-term adverse effects of proton pump inhibitors . A PubMed search for English language studies was conducted using key terms PPI: omeprazole, esomeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, pneumonia, Clostridium difficile, osteoporosis, risk of fractures, thrombocytopenia, rhabdomyolysis, anemia, iron deficiency, hypomagnesemia, vitamin Ba a and nephritis.

    Comment?

  14. Embarrassing Bodies' Dr Pixie answers the sexual health...Read the original story w/Photo

    Sep 17, 2015 | Mirror.co.uk

    Many of us still feel uncomfortable visiting the doctor with a sensitive issue - even though they are trained health professionals. We then enlisted the help Embarrassing Bodies' resident GP and Superdrug's health and wellbeing ambassador Dr Pixie McKenna to address your concerns.

    Comment?

  15. Gastric Acid Suppressants and Association With Fractures in WomenRead the original story

    Sep 15, 2015 | US Pharmacist

    ABSTRACT: Proton pump inhibitors and histamine2 receptor antagonists are heavily utilized gastric acid suppressants, and more potential adverse effects are being attributed to these agents. With gastrointestinal conditions increasingly commonplace, many patients are using PPIs continuously for years even though most of the drugs lack extensive long-term data and are FDA-approved for much shorter durations of therapy.

    Comment?

  16. Interindividual variability of CYP2C19-catalyzed drug metabolism due...Read the original story

    Sep 1, 2015 | The Pharmacogenomics Journal

    Correspondence: Professor KE Thummel, Department of Pharmaceutics, School of Pharmacy, University of Washington, H272 Health Sciences Building, Box 357610, Seattle, WA 98195-7610, USA. E-mail: [email protected] Large interindividual variability has been observed in the metabolism of CYP2C19 substrates in vivo .

    Comment?

  17. Fennel seeds helped break heartburn drug dependenceRead the original story w/Photo

    Aug 30, 2015 | Seattle Times

    Several years ago, a reader wrote about her success getting off the medicine by taking fennel seeds. I had the same problem and tried the fennel seeds.

    Comment?

  18. New drug for the treatment of erosive esophagitisRead the original story

    Aug 25, 2015 | GastroHep.com

    A study published in September's issue of the Alimentary Pharmacology & Therapeutics compares vonoprazan, a novel potassium-competitive acid blocker, with lansoprazole for the treatment of erosive esophagitis. The potassium-competitive acid blocker vonoprazan has potent acid-inhibitory effects and may offer clinical advantages over conventional therapy for acid-related disorders.

    Comment?

  19. Individualized Medications at Sienna Compounding PharmacyRead the original story w/Photo

    Aug 14, 2015 | Fort Bend Star

    What do you do when you need a medication that is not commercially available? Your baby needs a diaper rash ointment, eczema cream or lansoprazole suspension for acid reflux. Your teenager needs a customized acne medication.

    Comment?

  20. Regurgitation of foodRead the original story w/Photo

    Aug 5, 2015 | Ask MetaFilter

    For the past few months, I've been steadily spitting up food after I eat. If it acts up it tends to keep happening for hours after I have last eaten.

    Comment?